Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to determine whether remifentanil has a facilitating effect on the generation of burst suppression by propofol in adult patients (18-60 years) candidates for electiv...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Chile
NCT06725550 · Sickle Cell Disease, Pain, and more
NCT06878326 · Autism Spectrum Disorder (ASD), Transcranial Direct Current Stimulation (tDCS), and more
NCT06694402 · Focal Vibration, Electroencephalography, and more
NCT06190210 · Congenital Heart Disease, Neurodevelopmental Disorders, and more
NCT07251101 · Anesthesia, Intravenous, Hemodynamic Stability, and more
Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile
Santiago, RM
Hospital Clinico de la Universidad de Chile
Santiago, RM
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions